Skip to main content

Table 2 OR estimates for the association between PHR and frailty

From: Association of platelet-to-HDL cholesterol ratio with frailty and all-cause mortality

  

Model 0

Model 1

Model 2

Model 3

 

OR (95%CI)

P-value

OR (95%CI)

P-value

OR (95%CI)

P-value

OR (95%CI)

P-value

Frailty ~PHR

Quartile 1

reference

 

reference

 

reference

 

reference

  
 

Quartile 2

1.10(0.97,1.26)

0.15

1.16(1.01,1.33)

0.04

1.05(0.91,1.21)

0.54

1.00(0.85,1.18)

0.98

 
 

Quartile 3

1.26(1.09,1.46)

0.003

1.31(1.12,1.52)

<0.001

1.07(0.92,1.25)

0.36

0.99(0.84,1.16)

0.87

 
 

Quartile 4

1.74(1.49,2.02)

<0.0001

1.93(1.64,2.26)

<0.0001

1.47(1.24,1.74)

<0.0001

1.23(1.04,1.47)

0.02

 
 

P for trend

 

<0.0001

 

<0.0001

 

<0.0001

 

0.02

 
 

<166.7

0.96(0.89,1.04)

0.35

0.96(0.88,1.04)

0.32

0.91(0.83,0.99)

0.03

0.88(0.80,0.97)

0.01

 
 

≥166.7

1.22(1.14,1.30)

<0.0001

1.25(1.17,1.33)

<0.0001

1.17(1.09,1.25)

<0.0001

1.10(1.02,1.19)

0.01

 
  1. Notes: Model 0: Crude model. Model 1: Adjusted for age, sex, race, marital status, education, and poverty-income ratio. Model 2: Additionally adjusted for drinking, smoking, total energy intake, weekly physical activity level, and BMI. Model 3: Additionally, adjusted for diabetes, cancer, hypertension, CVD, blood cholesterol levels, blood triglyceride levels, lipid-lowering drugs and antiplatelet drugs. PHR, platelet/high-density lipoprotein cholesterol ratio; SD, standard deviation; BMI, body mass index; OR, odds ratio; CI, confidence interval
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X